JP2020511139A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020511139A5 JP2020511139A5 JP2019550795A JP2019550795A JP2020511139A5 JP 2020511139 A5 JP2020511139 A5 JP 2020511139A5 JP 2019550795 A JP2019550795 A JP 2019550795A JP 2019550795 A JP2019550795 A JP 2019550795A JP 2020511139 A5 JP2020511139 A5 JP 2020511139A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- seq
- salmonella
- protein
- acid sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022180850A JP2023021116A (ja) | 2017-03-17 | 2022-11-11 | がん免疫療法のための新規ｐｄ－ｌ１標的ｄｎａワクチン |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP17161666.7 | 2017-03-17 | ||
| EP17161666 | 2017-03-17 | ||
| EP17188941 | 2017-09-01 | ||
| EP17188941.3 | 2017-09-01 | ||
| PCT/EP2018/056721 WO2018167290A1 (en) | 2017-03-17 | 2018-03-16 | Novel pd-l1 targeting dna vaccine for cancer immunotherapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022180850A Division JP2023021116A (ja) | 2017-03-17 | 2022-11-11 | がん免疫療法のための新規ｐｄ－ｌ１標的ｄｎａワクチン |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020511139A JP2020511139A (ja) | 2020-04-16 |
| JP2020511139A5 true JP2020511139A5 (https=) | 2021-04-22 |
| JP7247097B2 JP7247097B2 (ja) | 2023-03-28 |
Family
ID=61627121
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019550795A Active JP7247097B2 (ja) | 2017-03-17 | 2018-03-16 | がん免疫療法のための新規ｐｄ－ｌ１標的ｄｎａワクチン |
| JP2022180850A Pending JP2023021116A (ja) | 2017-03-17 | 2022-11-11 | がん免疫療法のための新規ｐｄ－ｌ１標的ｄｎａワクチン |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022180850A Pending JP2023021116A (ja) | 2017-03-17 | 2022-11-11 | がん免疫療法のための新規ｐｄ－ｌ１標的ｄｎａワクチン |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US11357842B2 (https=) |
| EP (1) | EP3595704A1 (https=) |
| JP (2) | JP7247097B2 (https=) |
| KR (1) | KR20190125481A (https=) |
| CN (1) | CN110430893A (https=) |
| AU (1) | AU2018235153A1 (https=) |
| BR (1) | BR112019019251A2 (https=) |
| CA (1) | CA3056807A1 (https=) |
| IL (1) | IL268677A (https=) |
| MX (1) | MX2019011026A (https=) |
| RU (1) | RU2019132253A (https=) |
| SG (1) | SG11201908528UA (https=) |
| WO (1) | WO2018167290A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2018101722A (ru) * | 2015-06-18 | 2019-07-18 | Факсимм Аг | Днк-вакцина, нацеленная на vegfr-2, для комбинированной терапии |
| KR102851396B1 (ko) | 2019-10-10 | 2025-08-26 | 주식회사 엘지에너지솔루션 | 히팅 패드 제어 장치 |
| US20230121528A1 (en) | 2020-01-13 | 2023-04-20 | Vaximm Ag | Salmonella-based dna vaccines in combination with an antibiotic |
| CU24705B1 (es) | 2020-10-22 | 2024-06-11 | Ct Ingenieria Genetica Biotecnologia | Antígeno quimérico que comprende el dominio extracelular de pd-l1 |
| CN115645520A (zh) * | 2022-11-15 | 2023-01-31 | 中国科学技术大学 | 一种化疗诱导的肿瘤蛋白抗原纳米疫苗的制备方法及其应用 |
| CN118221773B (zh) * | 2024-02-05 | 2025-09-09 | 首都医科大学附属北京儿童医院保定医院 | 与HLA相关的CMV pp65表位疫苗组合物与应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0584266B1 (en) * | 1991-05-06 | 2003-09-03 | THE GOVERNMENT OF THE UNITED STATES OF AMERICA as represented by the SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Recombinant virus expressing carcinoembryonic antigen and methods of use thereof |
| JP2012500855A (ja) | 2008-08-25 | 2012-01-12 | アンプリミューン、インコーポレーテッド | Ｐｄ−１アンタゴニストおよび感染性疾患を処置するための方法 |
| CN102219860B (zh) * | 2011-05-20 | 2012-09-12 | 烟台荣昌生物工程有限公司 | FGFR-Fc融合蛋白及其用途 |
| EP4079319A1 (en) * | 2011-10-17 | 2022-10-26 | IO Biotech ApS | Pd-l1 based immunotherapy |
| JP6325534B2 (ja) | 2012-07-05 | 2018-05-16 | バクシム アクチェンゲゼルシャフト | 膵臓癌患者用ｄｎａワクチン |
| MX364922B (es) | 2013-04-25 | 2019-05-14 | Vaximm Ag | Vacuna de adn que dirige wt-1 novedosa para inmunoterapia contra cáncer. |
| TWI676636B (zh) * | 2013-07-12 | 2019-11-11 | Ｖｌｐ醫療股份有限公司 | 包含ｐｄ－１抗原或ｐｄ－１配體抗原的類病毒粒子 |
| SI3082850T1 (sl) * | 2013-12-18 | 2020-01-31 | Vaximm Gmbh | DNA cepivo, ki cilja MSLN za imunoterapijo raka |
| CA2935511C (en) * | 2014-01-07 | 2023-04-04 | Babita Agrawal | Immunomodulatory compositions comprising heat-killed caulobacter crescentus and methods of use thereof |
| US20180153976A1 (en) * | 2015-06-18 | 2018-06-07 | Vaximm Ag | Novel cmv pp65 targeting dna vaccine for cancer immunotherapy |
| RU2018101722A (ru) * | 2015-06-18 | 2019-07-18 | Факсимм Аг | Днк-вакцина, нацеленная на vegfr-2, для комбинированной терапии |
-
2018
- 2018-03-16 JP JP2019550795A patent/JP7247097B2/ja active Active
- 2018-03-16 MX MX2019011026A patent/MX2019011026A/es unknown
- 2018-03-16 RU RU2019132253A patent/RU2019132253A/ru not_active Application Discontinuation
- 2018-03-16 BR BR112019019251A patent/BR112019019251A2/pt not_active Application Discontinuation
- 2018-03-16 US US16/494,629 patent/US11357842B2/en active Active
- 2018-03-16 EP EP18710879.0A patent/EP3595704A1/en not_active Withdrawn
- 2018-03-16 WO PCT/EP2018/056721 patent/WO2018167290A1/en not_active Ceased
- 2018-03-16 CA CA3056807A patent/CA3056807A1/en not_active Abandoned
- 2018-03-16 AU AU2018235153A patent/AU2018235153A1/en not_active Abandoned
- 2018-03-16 SG SG11201908528U patent/SG11201908528UA/en unknown
- 2018-03-16 CN CN201880018761.6A patent/CN110430893A/zh active Pending
- 2018-03-16 KR KR1020197030279A patent/KR20190125481A/ko not_active Ceased
-
2019
- 2019-08-13 IL IL26867719A patent/IL268677A/en unknown
-
2022
- 2022-04-27 US US17/730,909 patent/US20220273782A1/en not_active Abandoned
- 2022-11-11 JP JP2022180850A patent/JP2023021116A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020511139A5 (https=) | ||
| Fan et al. | Lipopolyplex-formulated mRNA cancer vaccine elicits strong neoantigen-specific T cell responses and antitumor activity | |
| RU2019132253A (ru) | Новая днк-вакцина, нацеленная на pd-l1, для иммунотерапии рака | |
| Jiang et al. | Inhibition of tumor growth and metastasis by a combination of Escherichia coli–mediated cytolytic therapy and radiotherapy | |
| RU2016129044A (ru) | Новая вакцина днк, нацеленная на мезотелин, для иммунотерапии рака | |
| Kang et al. | Tumor-targeted delivery of IL-2 by NKG2D leads to accumulation of antigen-specific CD8+ T cells in the tumor loci and enhanced anti-tumor effects | |
| JP6945301B2 (ja) | Ｈｐｖおよび関連する疾病のための免疫増強治療ワクチン | |
| Weichselbaum | The 46th David A. Karnofsky Memorial Award lecture: oligometastasis—from conception to treatment | |
| EP2958994B1 (en) | Vaccine composition | |
| Mei et al. | Combining DNA vaccine and AIDA-1 in attenuated Salmonella activates tumor-specific CD4+ and CD8+ T-cell responses | |
| Chen et al. | Development of a Listeria monocytogenes-based vaccine against hepatocellular carcinoma | |
| JP2018517419A5 (https=) | ||
| JP2017525336A5 (https=) | ||
| Soong et al. | Xenogeneic human p53 DNA vaccination by electroporation breaks immune tolerance to control murine tumors expressing mouse p53 | |
| Zhao et al. | Autologous tumor vaccine modified with recombinant new castle disease virus expressing IL-7 promotes antitumor immune response | |
| RU2018101722A (ru) | Днк-вакцина, нацеленная на vegfr-2, для комбинированной терапии | |
| WO2014063601A1 (zh) | 诱导肿瘤特异性免疫的疫苗及其应用 | |
| BR112021001117A2 (pt) | células cancerígenas modificadas, composição farmacêutica, linha celular, métodos para fazer células cancerígenas modificadas e para estimular uma resposta imune, vetor de expressão isolado ou combinação de vetores de expressão isolados, e, uma ou mais células cancerígenas modificadas | |
| JP2020507332A5 (https=) | ||
| JP2015520129A (ja) | 多価乳がんワクチン | |
| CN110408634B (zh) | 一种非整合李斯特菌疫苗及抗肿瘤免疫应答方法 | |
| CN110564767A (zh) | 一种减毒病毒载体系统及其在制备抗恶性肿瘤的药物中的应用及药物使用方法 | |
| Jiang et al. | Engineered exosomes in service of tumor immunotherapy: From optimizing tumor‐derived exosomes to delivering CRISPR/Cas9 system | |
| RU2019125436A (ru) | Новый подход к иммунотерапии, нацеленной на vegfr-2 | |
| Riederer et al. | Improving poxvirus-mediated antitumor immune responses by deleting viral cGAMP-specific nuclease |